A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes
暂无分享,去创建一个
Kevin B. Jones | V. Sheffield | J. Buckwalter | M. Capecchi | P. Roughley | J. Morcuende | F. Grabellus | V. Piombo | C. Searby | A. Vortkamp | Baoli Yang | G. Kurriger
[1] M. Kmita,et al. Recombination between inverted loxP sites is cytotoxic for proliferating cells and provides a simple tool for conditional cell ablation , 2008, Proceedings of the National Academy of Sciences.
[2] C. Chien,et al. Regulation of Zebrafish Skeletogenesis by ext2/dackel and papst1/pinscher , 2008, PLoS genetics.
[3] M. Capecchi,et al. Two cell lineages, myf5 and myf5-independent, participate in mouse skeletal myogenesis. , 2008, Developmental cell.
[4] H. Kronenberg,et al. A Novel Transgenic Mouse Model to Study the Osteoblast Lineage in Vivo , 2007, Annals of the New York Academy of Sciences.
[5] A. Cleton-Jansen,et al. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. , 2007, Journal of the National Cancer Institute.
[6] A. Cleton-Jansen,et al. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas , 2007, The Journal of pathology.
[7] P. Roughley,et al. Generation of a transgenic mouse in which Cre recombinase is expressed under control of the type II collagen promoter and doxycycline administration. , 2006, Matrix biology : journal of the International Society for Matrix Biology.
[8] Z. Werb,et al. Mice deficient in Ext2 lack heparan sulfate and develop exostoses , 2005, Development.
[9] A. Vortkamp,et al. Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification. , 2004, Developmental cell.
[10] S. Selleck,et al. Abrogation of heparan sulfate synthesis in Drosophila disrupts the Wingless, Hedgehog and Decapentaplegic signaling pathways , 2004, Development.
[11] H. Kitagawa,et al. Heparin and Heparan Sulfate Biosynthesis , 2002, IUBMB life.
[12] W. Cole,et al. Heparan sulfate abnormalities in exostosis growth plates. , 2002, Bone.
[13] C. Tabin,et al. Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer , 2002, Genesis.
[14] K. Hashimoto,et al. Induced DNA recombination by Cre recombinase protein transduction , 2002, Genesis.
[15] Shi Tang,et al. A cre/loxP‐deleter transgenic line in mouse strain 129S1/SvImJ , 2002, Genesis.
[16] A. McMahon,et al. Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. , 2001, Development.
[17] A. Bradley,et al. Engineering chromosomal rearrangements in mice , 2001, Nature Reviews Genetics.
[18] J. Esko,et al. Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity. , 2001, American journal of human genetics.
[19] M. Lovett,et al. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes. , 2001, Cell motility and the cytoskeleton.
[20] H. Kitagawa,et al. The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis , 2000, EMBO reports.
[21] M. Matzuk,et al. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. , 2000, Developmental biology.
[22] D. Ovchinnikov,et al. Col2a1‐directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice , 2000, Genesis.
[23] C. McCormick,et al. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Cleton-Jansen,et al. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. , 1999, American journal of human genetics.
[25] D. Porter,et al. The neoplastic pathogenesis of solitary and multiple osteochondromas , 1999, The Journal of pathology.
[26] C. Lobe,et al. Z/AP, a double reporter for cre-mediated recombination. , 1999, Developmental biology.
[27] N. Rifai,et al. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes , 1999, Nature Genetics.
[28] K. Rajewsky,et al. Rapid elimination of mature autoreactive B cells demonstrated by Cre-induced change in B cell antigen receptor specificity in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] W. Klein,et al. Expression and functional analysis of mouse EXT1, a homolog of the human multiple exostoses type 1 gene. , 1998, Biochemical and biophysical research communications.
[30] G. Evans,et al. Gene for multiple exostoses (EXT2) maps to 11(p11.2p12) and is deleted in patients with a contiguous gene syndrome. , 1998, American journal of medical genetics.
[31] G. Mortier,et al. Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. , 1998, American journal of human genetics.
[32] H. Höfler,et al. Laser-assisted preparation of single cells from stained histological slides for gene analysis , 1997, Histochemistry and Cell Biology.
[33] G. Martin,et al. Cre–mediated chromosome loss in mice , 1997, Nature Genetics.
[34] W. Chan,et al. Clonality in nodular lymphocyte-predominant Hodgkin's disease. , 1997, The New England journal of medicine.
[35] Clifford J. Tabin,et al. Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein , 1996, Science.
[36] M. Scott,et al. Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog. , 1996, Genes & development.
[37] A. McMahon,et al. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. , 1995, Developmental biology.
[38] M. Wagner,et al. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1) , 1995, Nature Genetics.
[39] L. Strong,et al. Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. , 1995, American journal of human genetics.
[40] R. Pauli,et al. Natural history study of hereditary multiple exostoses. , 1995, American journal of medical genetics.
[41] L. Donehower,et al. Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice , 1993, Nature Genetics.
[42] R. Paniagua,et al. Osteochondroma induced by reflection of the perichondrial ring in young rat radii , 1987, Calcified Tissue International.
[43] K. Kohno,et al. Isolation and characterization of a cDNA clone for the amino-terminal portion of the pro-alpha 1(II) chain of cartilage collagen. , 1984, The Journal of biological chemistry.
[44] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. Winterpacht,et al. Ucma--A novel secreted factor represents a highly specific marker for distal chondrocytes. , 2008, Matrix biology : journal of the International Society for Matrix Biology.
[46] J. Bovée. Orphanet Journal of Rare Diseases BioMed Central Review Multiple osteochondromas , 2008 .
[47] M. Tada,et al. Targeted chromosome elimination from ES-somatic hybrid cells , 2007, Nature Methods.
[48] Philippe Soriano. Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.
[49] E. Wijsman,et al. Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses , 1998, Human mutation.
[50] L. Strong,et al. Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies. , 1997, American journal of human genetics.
[51] B. Olsen,et al. A dominant negative mutation in the alpha 1 (X) collagen gene produces spondylometaphyseal defects in mice. , 1993, Progress in clinical and biological research.